12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

MorphoSys sales and marketing update

MorphoSys said a HuCAL antibody from its AbD Serotec division was included for use in an undisclosed...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >